-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Sage Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q2 2018 to Q4 2024.
- Sage Therapeutics, Inc. Revenues for the quarter ending December 31, 2024 was $12.8M, a 83.6% decline year-over-year.
- Sage Therapeutics, Inc. Revenues for the twelve months ending December 31, 2024 was $41.2M, a 52.3% decline year-over-year.
- Sage Therapeutics, Inc. annual Revenues for 2024 was $41.2M, a 52.3% decline from 2023.
- Sage Therapeutics, Inc. annual Revenues for 2023 was $86.5M, a 1025% increase from 2022.
- Sage Therapeutics, Inc. annual Revenues for 2022 was $7.69M, a 21.8% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)